The burgeoning field ofinvestigations into novel anxiolytics is rapidly expanding, with emerging research chemicals showing favorable results in preclinical and clinical experiments. These substances often exhibit distinct mechanisms of action compared to traditional anti-anxiety medications, offering potential benefits for patients struggling with